Private equity firm Vivaris Capital announced its first structured financial product for United Cancer Centres (UCC) which provides investors with alternative asset investments while securing their principal.
The Vican combines a private equity investment with investment-grade securities, and gives clients the chance to invest in scenarios with high growth and return potential while only taking the risk of an investment grade fixed-income portfolio. “We take the investment proceeds and put half of it into a portfolio of securities that returns the face amount of the principal investment at the end of a term which is typically seven to 10 years,” said president and founder of Vivaris, Chr
Continue reading and get unlimited access for 7 days with a free trial of SRP.
Get a free trialAlready a subscriber? Login